Scapa Group (LON:SCPA) was upgraded by stock analysts at Numis Securities to an “add” rating in a research report issued to clients and investors on Tuesday. The brokerage currently has a GBX 485 ($6.53) price target on the stock. Numis Securities’ target price indicates a potential upside of 11.49% from the company’s previous close.

Other equities analysts have also issued reports about the company. Berenberg Bank reaffirmed a “buy” rating and issued a GBX 500 ($6.73) price objective on shares of Scapa Group in a research note on Friday, October 6th. N+1 Singer raised Scapa Group to a “buy” rating and set a GBX 490 ($6.59) price objective on the stock in a research note on Thursday, October 5th.

Scapa Group (SCPA) traded down GBX 4.75 ($0.06) during trading on Tuesday, reaching GBX 435 ($5.85). The company had a trading volume of 173,588 shares, compared to its average volume of 270,380. The stock has a market cap of $668.17 and a PE ratio of 3,107.14. Scapa Group has a 1 year low of GBX 316.75 ($4.26) and a 1 year high of GBX 522.39 ($7.03).

Scapa Group (LON:SCPA) last issued its quarterly earnings results on Tuesday, November 21st. The company reported GBX 8.30 ($0.11) earnings per share (EPS) for the quarter. Scapa Group had a return on equity of 21.69% and a net margin of 7.90%. The firm had revenue of £145.60 million for the quarter.

In other news, insider Graham Hardcastle purchased 15,000 shares of the stock in a transaction dated Monday, November 27th. The stock was acquired at an average cost of GBX 482 ($6.49) per share, for a total transaction of £72,300 ($97,308.21).

COPYRIGHT VIOLATION WARNING: “Scapa Group (SCPA) Upgraded to “Add” at Numis Securities” was reported by American Banking News and is the sole property of of American Banking News. If you are accessing this piece on another website, it was stolen and reposted in violation of U.S. and international copyright and trademark legislation. The original version of this piece can be viewed at

Scapa Group Company Profile

Scapa Group plc is a United Kingdom-based global supplier of bonding solutions and manufacturer of adhesive-based products for the Healthcare and Industrial markets. The Company has a global footprint, with production sites in Asia, Europe and the United States. The Company conducts the activities through two distinct and separate businesses: Healthcare and Industrial business units.

Receive News & Ratings for Scapa Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Scapa Group and related companies with's FREE daily email newsletter.